Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.26)
# 890
Out of 4,814 analysts
82
Total ratings
33.75%
Success rate
5.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $13.33 | +282.60% | 4 | Apr 2, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Overweight | $10 → $6 | $0.58 | +943.48% | 2 | Mar 7, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Overweight | $48 | $4.41 | +988.44% | 1 | Feb 28, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $94 → $110 | $9.31 | +1,082.16% | 2 | Feb 26, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Overweight | $93 | $32.30 | +187.93% | 1 | Jan 23, 2025 | |
| UPB Upstream Bio | Initiates: Overweight | $75 | $9.72 | +672.00% | 1 | Nov 5, 2024 | |
| NKTR Nektar Therapeutics | Initiates: Overweight | $7 | $0.62 | +1,021.62% | 1 | Nov 4, 2024 | |
| SAGE Sage Therapeutics | Reiterates: Overweight | $52 → $26 | $7.45 | +249.23% | 2 | Oct 30, 2024 | |
| NAMS NewAmsterdam Pharma Company | Reiterates: Overweight | $37 | $16.26 | +127.55% | 2 | Sep 23, 2024 | |
| ZURA Zura Bio | Maintains: Overweight | $26 | $1.37 | +1,804.76% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $20 | $2.29 | +773.36% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.99 | +2,728.00% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $30.17 | +221.51% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $35.34 | +664.01% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $17.92 | +324.11% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $4.80 | +421.38% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $13.74 | +118.34% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $3.54 | +239.46% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $36 | $60.11 | -40.11% | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.61 | +1,367.71% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $13.64 | +1,219.65% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $0.81 | +1,745.02% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $295.79 | +13.59% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $3.06 | +423.73% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $20.60 | +288.35% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $69.21 | +34.37% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $23.10 | +302.60% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $16.85 | +285.87% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $14.48 | +293.65% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $2.41 | +2,685.86% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $45.56 | -23.18% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $22 | $0.33 | +6,669.23% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $5.23 | +1,563.48% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $4.62 | +3,687.88% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $37.93 | +89.82% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $27 | $1.50 | +1,706.02% | 1 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $6.26 | +203.51% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $1.14 | +4,305.29% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.47 | +8,489.22% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.32 | +5,558.60% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $9.55 | +4,297.91% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $11.00 | +600.32% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $38.41 | +100.47% | 1 | Jul 31, 2020 |
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $13.33
Upside: +282.60%
Lexicon Pharmaceuticals
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $0.58
Upside: +943.48%
Avalo Therapeutics
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $4.41
Upside: +988.44%
Prothena Corporation
Feb 26, 2025
Maintains: Overweight
Price Target: $94 → $110
Current: $9.31
Upside: +1,082.16%
Bright Minds Biosciences
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $32.30
Upside: +187.93%
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $9.72
Upside: +672.00%
Nektar Therapeutics
Nov 4, 2024
Initiates: Overweight
Price Target: $7
Current: $0.62
Upside: +1,021.62%
Sage Therapeutics
Oct 30, 2024
Reiterates: Overweight
Price Target: $52 → $26
Current: $7.45
Upside: +249.23%
NewAmsterdam Pharma Company
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $16.26
Upside: +127.55%
Zura Bio
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $1.37
Upside: +1,804.76%
Aug 14, 2024
Maintains: Overweight
Price Target: $68 → $20
Current: $2.29
Upside: +773.36%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.99
Upside: +2,728.00%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $30.17
Upside: +221.51%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $35.34
Upside: +664.01%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $17.92
Upside: +324.11%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $4.80
Upside: +421.38%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $13.74
Upside: +118.34%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $3.54
Upside: +239.46%
Apr 16, 2024
Maintains: Overweight
Price Target: $31 → $36
Current: $60.11
Upside: -40.11%
Apr 4, 2024
Initiates: Overweight
Price Target: $9
Current: $0.61
Upside: +1,367.71%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $13.64
Upside: +1,219.65%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $0.81
Upside: +1,745.02%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $295.79
Upside: +13.59%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $3.06
Upside: +423.73%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $20.60
Upside: +288.35%
Feb 5, 2024
Initiates: Overweight
Price Target: $93
Current: $69.21
Upside: +34.37%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $23.10
Upside: +302.60%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $16.85
Upside: +285.87%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $14.48
Upside: +293.65%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $2.41
Upside: +2,685.86%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $45.56
Upside: -23.18%
Mar 7, 2023
Initiates: Overweight
Price Target: $22
Current: $0.33
Upside: +6,669.23%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $5.23
Upside: +1,563.48%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $4.62
Upside: +3,687.88%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $37.93
Upside: +89.82%
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $1.50
Upside: +1,706.02%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $6.26
Upside: +203.51%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $1.14
Upside: +4,305.29%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.47
Upside: +8,489.22%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.32
Upside: +5,558.60%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $9.55
Upside: +4,297.91%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $11.00
Upside: +600.32%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $38.41
Upside: +100.47%